<DOC>
	<DOCNO>NCT02433730</DOCNO>
	<brief_summary>The purpose study evaluate efficacy testosterone replacement therapy men low testosterone due opioid treatment body composition , haemostatic system , glucose metabolism , muscle function , pain sensitivity , pain modulation , lipid , sexual function quality life . Male patient opioids non-malignant disease age 18-59 year diagnose hypogonadotrophic hypogonadism , refer day hospital outpatient population . 40 patient randomize either testosterone undecanoate i.m . placebo i.m. , i.e . 20 patient per arm A double blind randomize placebo control trial</brief_summary>
	<brief_title>Testosterone Therapy Hypogonadal Men Treated With Opioids</brief_title>
	<detailed_description>The study duration 24 week . Patients treat Testosterone Undecanoate 1000 mg/4 ml , intramuscular ( i.m . ) placebo 0 , 6 18 week . Outcome measure evaluate 0 14 week .</detailed_description>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Male patient 1859 year Treatment opioid &gt; 3 month , daily dose &gt; 50100 mg Total testosterone &lt; 10 mmol/L Follicle Stimulating Hormone ( FSH ) /Luteinizing Hormone ( LH ) level normal og normal laboratory value Normal prolactin level Hematocrit &gt; 54 % screen Prostate Specific Antigen ( PSA ) &gt; 3 ng/ml Routine blood sample value range ( thyroid stimulate hormone ; ionized calcium , hemoglobin , liver kidney function test ) Severe organic mental disease Past present prostate cancer og breastcancer Past present liver tumor og acute chronic liver diseases Any current diagnosis og cancer Acute thromboembolic disease Previous venous thrombotic embolism cerebrovascular disease Uncontrolled hypertension Chronic debilitate disease Epilepsy migraine adequately control therapy Severe benign prostate hypertrophy symptom score &gt; 19 Sleep apnea Alcohol drug abuse Implantation sustain action sex hormone last 12 month Use oral , buccal transdermal testosterone last two week Blood coagulation irregularity present af risk bleed intramuscular injection Treatment glucocorticoid &gt; 5 mg/day 5 alfa reductase inhibitor Hypersensitivity Nebido Body mass index &gt; 40 kg/m2</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>